AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1

Historical Holders from Q1 2014 to Q1 2019

Type / Class
Debt / NOTE 2.500% 2/1
All holders as of 31 Mar 2019
Q1 2019
Total 13F principal, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-9
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1

Period Principal Value Change Price Investors
2019 Q1 0 $0 -$20,840,000 0
2018 Q4 21,164,000 $20,840,000 +$27,695 $1 9
2018 Q3 21,168,000 $21,157,000 -$19,787 $1 9
2018 Q2 21,188,000 $21,933,000 -$8,463,193 $1 9
2018 Q1 21,608,000 $30,019,811 +$8,447,911 $1 11
2017 Q4 21,202,000 $21,208,542 -$276,829 $1 10
2017 Q3 21,237,000 $22,502,961 -$17,754,380 $1.04 11
2017 Q2 38,174,000 $39,681,566 -$170,888,151 $1.04 13
2017 Q1 194,558,000 $212,339,691 -$20,352,219 $1.09 29
2016 Q4 202,207,000 $286,123,558 +$6,924,912 $1.41 28
2016 Q3 201,310,000 $227,670,676 +$3,488,981 $1.13 30
2016 Q2 189,113,000 $209,111,391 +$2,799,996 $1.11 31
2016 Q1 199,145,000 $216,207,454 -$396,601,348 $1.08 27
2015 Q4 185,454,000 $638,804,000 -$22,023,570 $1.26 31
2015 Q3 197,332,000 $320,216,000 -$11,572,212 $1.61 25
2015 Q2 190,382,000 $492,291,000 +$15,456,373 $2.59 26
2015 Q1 191,875,000 $398,604,520 +$11,132,904 $2.08 28
2014 Q4 197,124,000 $329,441,000 -$121,050,589 $1.67 21
2014 Q3 193,600,000 $392,859,992 +$136,209,655 $1.34 21
2014 Q2 192,477,000 $204,310,000 +$11,569,465 $1.06 20
2014 Q1 182,198,611 $185,244,707 +$163,708,707 $1.02 24